Trade Summary

Yesterday, HILZINGER KURT J, serving as Dir at Outlook Therapeutics, Inc. (OTLK), purchased 400,000 shares at $0.44 per share, for a total transaction value of $176,520.00. Following this transaction, HILZINGER KURT J now holds 423,655 shares of OTLK.

This purchase represents a 1690.97% increase in HILZINGER KURT J's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Tuesday, May 26, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 27, 2026 at 3:15 PM ET, 1 day after the trade was made.

Outlook Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.